NCT06465316
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06465316
Title Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital in Arizona RECRUITING Phoenix Arizona 85054 United States Details
Smilow Cancer Hospital Care Center - Guilford RECRUITING Guilford Connecticut 06437 United States Details
Yale University RECRUITING New Haven Connecticut 06520 United States Details
Yale-New Haven Hospital North Haven Medical Center RECRUITING North Haven Connecticut 06473 United States Details
Mayo Clinic in Florida RECRUITING Jacksonville Florida 32224-9980 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
University of Kansas Cancer Center RECRUITING Kansas City Kansas 66160 United States Details
University of Kansas Cancer Center-Overland Park RECRUITING Overland Park Kansas 66210 United States Details
University of Kansas Hospital-Westwood Cancer Center RECRUITING Westwood Kansas 66205 United States Details
Mayo Clinic in Rochester RECRUITING Rochester Minnesota 55905 United States Details
Ohio State University Comprehensive Cancer Center RECRUITING Columbus Ohio 43210 United States Details
University of Oklahoma Health Sciences Center SUSPENDED Oklahoma City Oklahoma 73104 United States Details
VCU Massey Comprehensive Cancer Center RECRUITING Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field